Medicinal Attributes of Pyrazoline in Drug Discovery

References

1. DipankarB. HirakmoyC. AsishB. AbhijitC. 2-pyrazoline: A pharmacologically active moiety.Int. Res. J. Pharm. Appl. Sci.201116880
   [Google Scholar]
2. KumarS. BawaS. DrabuS. KumarR. GuptaH. Biological activities of pyrazoline derivatives--a recent development. Recent pat antiinfect.Drug Discov.200911154163
   [Google Scholar]
3. ShaabanM.R. MayhoubA.S. FaragA.M. Recent advances in the therapeutic applications of pyrazolines.Expert Opin. Ther. Pat.201222325329110.1517/13543776.2012.667403 22397588
   [Google Scholar]
4. WangH.H. QiuK.M. CuiH.E. YangY.S. Yin-LuoM. XingM. QiuX.Y. BaiL.F. ZhuH.L. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents.Bioorg. Med. Chem.201321244845510.1016/j.bmc.2012.11.020 23245802
   [Google Scholar]
5. RathoreP. YaseenS. OvaisS. BashirR. YaseenR. HameedA.D. SamimM. GuptaR. HussainF. JavedK. Synthesis and evaluation of some new pyrazoline substituted benzenesulfonylureas as potential antiproliferative agents.Bioorg. Med. Chem. Lett.20142471685169110.1016/j.bmcl.2014.02.059 24630557
   [Google Scholar]
6. ÖzdemirZ. KandilciH.B. GümüşelB. ÇalışÜ. BilginA.A. Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives.Eur. J. Med. Chem.200742337337910.1016/j.ejmech.2006.09.006 17069933
   [Google Scholar]
7. OzdemirZ. KandilciH.B. GumuselB. CalisU. BilginA.A. Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-thienyl)pyrazoline derivatives.Arch. Pharm.20083411170170710.1002/ardp.200800068 18816586
   [Google Scholar]
8. AggarwalR. BansalA. RozasI. KellyB. KaushikP. KaushikD. Synthesis, biological evaluation and molecular modeling study of 5-trifluoromethyl-Δ2-pyrazoline and isomeric 5/3-trifluoromethylpyrazole derivatives as anti-inflammatory agents.Eur. J. Med. Chem.20137035035710.1016/j.ejmech.2013.09.052 24177361
   [Google Scholar]
9. KharbandaC. AlamM.S. HamidH. JavedK. BanoS. DhulapA. AliY. NazreenS. HaiderS. Synthesis and evaluation of pyrazolines bearing benzothiazole as anti-inflammatory agents.Bioorg. Med. Chem.201422215804581210.1016/j.bmc.2014.09.028 25311566
   [Google Scholar]
10. AliM.A. ShaharyarM. SiddiquiA.A. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives.Eur. J. Med. Chem.200742226827510.1016/j.ejmech.2006.08.004 17007966
    [Google Scholar]
11. Rajendra PrasadY. Lakshmana RaoA. PrasoonaL. MuraliK. Ravi KumarP. Synthesis and antidepressant activity of some 1,3,5-triphenyl-2-pyrazolines and 3-(2″-hydroxy naphthalen-1″-yl)-1,5-diphenyl-2-pyrazolines.Bioorg. Med. Chem. Lett.200515225030503410.1016/j.bmcl.2005.08.040 16168645
    [Google Scholar]
12. KaplancıklıZ.A. ÖzdemirA. Turan-ZitouniG. AltıntopM.D. CanÖ.D. New pyrazoline derivatives and their antidepressant activity.Eur. J. Med. Chem.20104594383438710.1016/j.ejmech.2010.06.011 20587366
    [Google Scholar]
13. ÖzdemirA. Turan-ZitouniG. Asım KaplancıklıZ. RevialG. GüvenK. Synthesis and antimicrobial activity of 1-(4-aryl-2-thiazolyl)-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives.Eur. J. Med. Chem.200742340340910.1016/j.ejmech.2006.10.001 17125888
    [Google Scholar]
14. MongaV. GoyalK. SteindelM. MalhotraM. RajaniD.P. RajaniS.D. Synthesis and evaluation of new chalcones, derived pyrazoline and cyclohexenone derivatives as potent antimicrobial, antitubercular and antileishmanial agents.Med. Chem. Res.20142342019203210.1007/s00044‑013‑0803‑1
    [Google Scholar]
15. KaplancikliZ.A. Turan-ZitouniG. ÖzdemirA. Devrim CanÖ. ChevalletP. Synthesis and antinociceptive activities of some pyrazoline derivatives.Eur. J. Med. Chem.20094462606261010.1016/j.ejmech.2008.09.002 18922604
    [Google Scholar]
16. AcharyaB.N. SaraswatD. TiwariM. ShrivastavaA.K. GhorpadeR. BapnaS. KaushikM.P. Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines.Eur. J. Med. Chem.201045243043810.1016/j.ejmech.2009.10.023 19926176
    [Google Scholar]
17. HassanS. Synthesis, antibacterial and antifungal activity of some new pyrazoline and pyrazole derivatives.Molecules20131832683271110.3390/molecules18032683 23449067
    [Google Scholar]
18. BhatA.R. AtharF. AzamA. New derivatives of 3,5-substituted-1,4,2-dioxazoles: Synthesis and activity against Entamoeba histolytica.Eur. J. Med. Chem.200944292693610.1016/j.ejmech.2008.02.001 18384916
    [Google Scholar]
19. HavrylyukD. ZimenkovskyB. KarpenkoO. GrellierP. LesykR. Synthesis of pyrazoline-thiazolidinone hybrids with trypanocidal activity.Eur. J. Med. Chem.20148524525410.1016/j.ejmech.2014.07.103 25089808
    [Google Scholar]
20. Gökhan-KelekçiN. KoyunoğluS. YabanoğluS. YelekçiK. ÖzgenÖ. UçarG. ErolK. KendiE. YeşiladaA. New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.Bioorg. Med. Chem.200917267568910.1016/j.bmc.2008.11.068 19091581
    [Google Scholar]
21. BhutaniR. PathakD.P. HusainA. KapoorG. KantR. A review on recent development of pyrazoline as a pharmocologically active molecule.Int. J. Pharm. Sci. Res.201564113
    [Google Scholar]
22. AlexK. TillackA. SchwarzN. BellerM. Zinc-catalyzed synthesis of pyrazolines and pyrazoles via hydrohydrazination.Org. Lett.200810122377237910.1021/ol800592s 18503279
    [Google Scholar]
23. ContiP. PintoA. TamboriniL. RizzoV. MicheliC.D. A regioselective route to 5-substituted pyrazole and -2-pyrazolines.Tetrahedron2007635554556010.1016/j.tet.2007.04.027
    [Google Scholar]
24. SinghP. NegiJ.S. PantG.J.N. RawatM.S.M. BudakotiA. 5-(3-Nitrophenyl)-3-phenyl-4,5-dihydro-1H-pyrazole-1-carbaldehyde.Tetrahedron2009614618
    [Google Scholar]
25. LiJ.T. ZhangX.H. LinZ.P. An improved synthesis of 1,3,5-triaryl-2-pyrazolines in acetic acid aqueous solution under ultrasound irradiation.Beilstein J. Org. Chem.200731310.1186/1860‑5397‑3‑13 17374170
    [Google Scholar]
26. KaruppasamyM. MahapatraM. YabanogluS. UcarG. SinhaB.N. BasuA. MishraN. SharonA. KulandaiveluU. JayaprakashV. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.Bioorg. Med. Chem.20101851875188110.1016/j.bmc.2010.01.043 20149663
    [Google Scholar]
27. LevaiL. JekoJ. A simple efficient procedure for the stereoselective synthesis of trans-2,3,3a,4-[1]benzothiopyrano analogues.Acta Chim. Slov.200956566570
    [Google Scholar]
28. Surendra KumarR. ArifI.A. AhamedA. IdhayadhullaA. Anti-inflammatory and antimicrobial activities of novel pyrazole analogues.Saudi J. Biol. Sci.201623561462010.1016/j.sjbs.2015.07.005 27579011
    [Google Scholar]
29. ChenY. TortoriciM.A. GarrettM. HeeB. KlamerusK.J. PithavalaY.K. Clinical pharmacology of axitinib.Clin. Pharmacokinet.201352971372510.1007/s40262‑013‑0068‑3 23677771
    [Google Scholar]
30. ParmarS. PatelK. Pinilla-IbarzJ. Ibrutinib (imbruvica): A novel targeted therapy for chronic lymphocytic leukemia.P t2014397483519 25083126
    [Google Scholar]
31. ChorvatR.J. BerbaumJ. SeriackiK. McElroyJ.F. Peripherally restricted CB1 receptor blockers.Bioorg. Med. Chem. Lett.201323174751476010.1016/j.bmcl.2013.06.066 23902803
    [Google Scholar]
32. SantosaA. RumbianaA. WahabZ. KurniawanS.P. NaibahoR.M. YogyartonoP. Successful treatment of methampyrone-induced toxic epidermal necrolysis with therapeutic plasma exchange.Case Rep. Med.201820181410.1155/2018/2182604
    [Google Scholar]
33. ShaikA. BhandareR.R. PalleapatiK. NissankararaoS. KancharlapalliV. ShaikS. Antimicrobial, antioxidant, and anticancer activities of some novel isoxazole ring containing chalcone and dihydropyrazole derivatives.Molecules20202551047105810.3390/molecules25051047 32110945
    [Google Scholar]
34. LhoD. ShinH. ParkJ. Simultaneous determination of morazone and phenmetrazine in rat plasma and urine using an on-column injection technique with fused-silica capillary column gas chromatography.J. Anal. Toxicol.199014211311510.1093/jat/14.2.113 1969972
    [Google Scholar]
35. ChavanR.R. HosamaniK.M. Microwave-assisted synthesis, computational studies and antibacterial/anti-inflammatory activities of compounds based on coumarin-pyrazole hybrid.R. Soc. Open Sci.20185517243517245110.1098/rsos.172435 29892430
    [Google Scholar]
36. ZengY. ZhuG. ZhuM. SongJ. CaiH. Edaravone attenuated particulate matter-induced lung inflammation by inhibiting ROS-NF-κB signaling pathway.Oxid. Med. Cell. Longev.202211110.1155/2022/2242833
    [Google Scholar]
37. LupuG. BelL. AndreiS. Pain management and analgesics used in small mammals during post-operative period with an emphasis on metamizole (dipyrone) as an alternative medication.Molecules202227217434744410.3390/molecules27217434 36364259
    [Google Scholar]
38. ReinosoR.F. FarránR. MoragónT. García-SoretA. MartínezL. Pharmacokinetics of E-6087, a new anti-inflammatory agent, in rats and dogs.Biopharm. Drug Dispos.200122623124210.1002/bdd.258 11754039
    [Google Scholar]
39. PrickaertsJ. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.Neurobiol. Learn. Mem.201093522531
    [Google Scholar]
40. NepaliK. SharmaS. SharmaM. BediP.M.S. DharK.L. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids.Eur. J. Med. Chem.20147742248710.1016/j.ejmech.2014.03.018 24685980
    [Google Scholar]
41. ChangL.C. LinH.Y. TsaiM.T. ChouR.H. LeeF.Y. TengC.M. HsiehM.T. HungH.Y. HuangL.J. YuY.L. KuoS.C.Y.C. ‐1 inhibits proliferation of breast cancer cells by down‐regulating EZH 2 expression via activation of c‐ C bl and ERK.Br. J. Pharmacol.2014171174010402510.1111/bph.12708 24697523
    [Google Scholar]
42. SchöffskiP. CrestaS. MayerI.A. WildiersH. DamianS. GendreauS. RooneyI. MorrisseyK.M. SpoerkeJ.M. NgV.W. SingelS.M. WinerE. A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer.Breast Cancer Res.201820110912110.1186/s13058‑018‑1015‑x 30185228
    [Google Scholar]
43. AckerT.M. LiottaD.C. StephenF. JingT.Y. Pyrazoline dihydroquinolones, pharmaceutical compositions, and uses.U.S. Patent 11117882B22021
44. LongLu. CassayreJ. Y. BerthonG. El QacemiM. YamingWu. Pyrazoline derivatives as insecticidal compounds.E.P. Patent 2948439b12020
45. BuschmannH.H. Torrens-JoverA. Mas-PrioJ. Yenes-MinguezS. Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators.W.O. Patent 20080435442008
46. ZilaoutB. 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists.W.O. Patent 20090372442009
47. AdamsR.S. DuffeyM. GouldA.E. GreenspanP.D. KulkarniB.A. VosT.J. Certain pyrazoline derivatives with kinase inhibitory activity. W.O. Patent 20080792772008
48. BuschmannH. H. Torrens-JoverA. Yenes MinguezS. Benet-BuchholzJ. Sola-CarandellL. Gamma-polymorph of a substituted pyrazoline, its preparation and use as medicaments.E.P. Patent 1944294A12008
49. BuschmannH.H. Cb1 antagonists or inverse antagonists as therapeutical agents for the treatment of inflammation involving gene expression.W.O. Patent 20070171252007
50. PintoD.J.P. Disubstituted pyrazolines and triazolines as factor Xa inhibitors.U.S. Patent 200100001792001
51. PassedouetA.H. RoussosM.G. PigeotJ. PailloleN. 1 3-diaryl- 1 2-pyrazolines and their preparation.U.S. Patent 36525841972
52. HaiderK. ShafeequeM. YahyaS. YarM.S. A comprehensive review on pyrazoline based heterocyclic hybrids as potent anticancer agents.Eur. J. Med. Chem.20225100042100069
    [Google Scholar]
53. MarivelS. BragaD. GrepioniF. LamprontiG.I. Mechanochemical preparation of adducts (co-crystals and molecular salts) of 1,4-diazabicyclo-[2.2.2]-octane with aromatic polycarboxylic acids.CrystEngComm20101272107211210.1039/b922915a
    [Google Scholar]
54. EdreesM. MelhaS. SaadA. KhederN. GomhaS. MuhammadZ. Eco-friendly synthesis, characterization and biological evaluation of some novel pyrazolines containing thiazole moiety as potential anticancer and antimicrobial agents.Molecules201823112970297410.3390/molecules23112970 30441815
    [Google Scholar]
55. RavulaP. VamarajuH.B. PaturiM. BodigeS. GulipalliK.C. Narendra Sharath ChandraJ.N. Design, synthesis, and docking studies of novel dimethyl triazene incorporated thiazolyl pyrazolines for anticancer activity.J. Heterocycl. Chem.20185561313132310.1002/jhet.3163
    [Google Scholar]
56. ChenK. ZhangY.L. FanJ. MaX. QinY.J. ZhuH.L. Novel nicotinoyl pyrazoline derivates bearing N-methyl indole moiety as antitumor agents: Design, synthesis and evaluation.Eur. J. Med. Chem.201815672273710.1016/j.ejmech.2018.07.044 30041136
    [Google Scholar]
57. MorenoL. QuirogaJ. AboniaR. Ramírez-PradaJ. InsuastyB. Synthesis of new 1,3,5-triazine-based 2-pyrazolines as potential anticancer agents.Molecules20182381956197610.3390/molecules23081956 30082588
    [Google Scholar]
58. AboniaR. CortésE. InsuastyB. QuirogaJ. NoguerasM. CoboJ. Synthesis of novel 1,2,5-trisubstituted benzimidazoles as potential antitumor agents.Eur. J. Med. Chem.20114694062407010.1016/j.ejmech.2011.06.006 21719162
    [Google Scholar]
59. MatiadisD. MavroidiB. PanagiotopoulouA. MethenitisC. PelecanouM. SagnouM. (E)-(1-(4-ethoxycarbonylphenyl)-5-(3,4-dimethoxyphenyl)-3-(3,4-dimethoxystyryl)-2-pyrazoline: synthesis, characterization, dna-interaction, and evaluation of activity against drug-resistant cell lines.Molbank202020201M1114M111910.3390/M1114
    [Google Scholar]
60. KuthyalaS. NagarajaG.K. SheikS. HanumanthappaM. KumarS. M.; Prabhu, A. Synthesis of imidazo [1, 2-a]pyridine-chalcones as potent inhibitors against A549 cell line and their crystal studies.J. Mol. Struct.2019117738139010.1016/j.molstruc.2018.09.087
    [Google Scholar]
61. GangarapuK. ThummaG. MandaS. JallapallyA. JarapulaR. RekulapallyS. Design, synthesis and molecular docking of novel structural hybrids of substituted isatin based pyrazoline and thiadiazoline as antitumor agents.Med. Chem. Res.201726481982910.1007/s00044‑017‑1781‑5
    [Google Scholar]
62. KumarR. SinghH. MazumderA. Salahuddin; Yadav, R.K. Synthetic approaches, biological activities, and structure-activity relationship of pyrazolines and related derivatives.Top. Curr. Chem.20233813121810.1007/s41061‑023‑00422‑z 37029841
    [Google Scholar]
63. AminK.M. EissaA.A.M. Abou-SeriS.M. AwadallahF.M. HassanG.S. Synthesis and biological evaluation of novel coumarin–pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents.Eur. J. Med. Chem.20136018719810.1016/j.ejmech.2012.12.004 23291120
    [Google Scholar]
64. InsuastyB. RamírezJ. BecerraD. EcheverryC. QuirogaJ. AboniaR. RobledoS.M. VélezI.D. UpeguiY. MuñozJ.A. OspinaV. NoguerasM. CoboJ. An efficient synthesis of new caffeine-based chalcones, pyrazolines and pyrazolo[3,4-b][1,4]diazepines as potential antimalarial, antitrypanosomal and antileishmanial agents.Eur. J. Med. Chem.20159340141310.1016/j.ejmech.2015.02.040 25725376
    [Google Scholar]
65. KaradS.C. PurohitV.B. ThakorP. ThakkarV.R. RavalD.K. Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.Eur. J. Med. Chem.201611227027910.1016/j.ejmech.2016.02.016 26900659
    [Google Scholar]
66. MishraV.K. MishraM. KashawV. KashawS.K. Synthesis of 1,3,5-trisubstituted pyrazolines as potential antimalarial and antimicrobial agents.Bioorg. Med. Chem.20172561949196210.1016/j.bmc.2017.02.025 28237557
    [Google Scholar]
67. PandeyA.K. SharmaS. PandeyM. AlamM.M. ShaquiquzzamanM. AkhterM. 4, 5-Dihydrooxazole-pyrazoline hybrids: Synthesis and their evaluation as potential antimalarial agents.Eur. J. Med. Chem.201612347648610.1016/j.ejmech.2016.07.055 27494165
    [Google Scholar]
68. AkhtarW. KhanM.F. VermaG. ShaquiquzzamanM. AkhterM. MarellaA. ParmarS. KhatoonR. AlamM.M. Coumarin-pyrazoline derivatives: Their one-pot microwave assisted synthesis and antimalarial activity.J. Pharmaceut. Med. Chem.2017369
    [Google Scholar]
69. AkhterW. MarellaA. ShaquiquzzamanM. AkhterM. AlamM.M. Microwave assissted synthesis of pyrazoline-coumarin hybrids and their in-vitro antimalarial evaluation.J. Pharm. Res.20159318322
    [Google Scholar]
70. ThachT.D. LeT. NguyenT.A. DangC.H. DangV.S. NguyenT.D. Synthesis of sulfonamides bearing 1,3,5-triarylpyrazoline and 4-thiazolidinone moieties as novel antimicrobial agents.J. Serb. Chem. Soc.202085215516210.2298/JSC180621057T
    [Google Scholar]
71. AlmahdiM.M. SaeedA.E.M. MetwallyN.H. Synthesis and antimicrobial activity of some new pyrazoline derivatives bearing sulfanilamido moiety.Eur. J. Chem.2019101303610.5155/eurjchem.10.1.30‑36.1791
    [Google Scholar]
72. ShamsuzzamanH. KhanamH. DarA.M. SiddiquiN. RehmanS. Synthesis, characterization, antimicrobial and anticancer studies of new steroidal pyrazolines.J. Saudi Chem. Soc.201620171210.1016/j.jscs.2012.05.004
    [Google Scholar]
73. MontoyaA. QuirogaJ. AboniaR. DeritaM. SortinoM. OrnelasA. ZacchinoS. InsuastyB. Hybrid molecules containing a 7-chloro-4-aminoquinoline nucleus and a substituted 2-pyrazoline with antiproliferative and antifungal activity.Molecules201621896997810.3390/molecules21080969 27472314
    [Google Scholar]
74. DeloguG.L. PintusF. MayánL. MatosM.J. VilarS. MunínJ. FontenlaJ.A. HripcsakG. BorgesF. ViñaD. MAO inhibitory activity of bromo-2-phenylbenzofurans: Synthesis, in vitro study, and docking calculations.MedChemComm2017891788179610.1039/C7MD00311K 30108888
    [Google Scholar]
75. PalaskaE. AytemirM. UzbayI.T. ErolD. Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines.Eur. J. Med. Chem.200136653954310.1016/S0223‑5234(01)01243‑0 11525844
    [Google Scholar]
76. Gökhan-KelekçiN. YabanoğluS. KüpeliE. SalgınU. ÖzgenÖ. UçarG. YeşiladaE. KendiE. YeşiladaA. BilginA.A. A new therapeutic approach in Alzheimer disease: Some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics.Bioorg. Med. Chem.200715175775578610.1016/j.bmc.2007.06.004 17611112
    [Google Scholar]
77. JayaprakashV. SinhaB.N. UcarG. ErcanA. Pyrazoline-based mycobactin analogues as MAO-inhibitors.Bioorg. Med. Chem. Lett.200818246362636810.1016/j.bmcl.2008.10.084 18980841
    [Google Scholar]
78. ChimentiF. FioravantiR. BolascoA. MannaF. ChimentiP. SecciD. RossiF. TuriniP. OrtusoF. AlcaroS. CardiaM.C. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.Eur. J. Med. Chem.200843102262226710.1016/j.ejmech.2007.12.026 18281126
    [Google Scholar]
79. TripathiA.C. UpadhyayS. PaliwalS. SarafS.K. An expeditious one-pot microwave facilitated versus conventional syntheses: In vivo biological screening and molecular docking studies of some 3,5-disubstituted-4,5-dihydro-(1H)-pyrazole derivatives.Med. Chem. Res.201625339040610.1007/s00044‑015‑1489‑3
    [Google Scholar]
80. EidN.M. GeorgeR.F. Facile synthesis of some pyrazoline-based compounds with promising anti-inflammatory activity.Future Med. Chem.201810218319910.4155/fmc‑2017‑0144 29185353
    [Google Scholar]
81. ChenL.Z. SunW.W. BoL. WangJ.Q. XiuC. TangW.J. ShiJ.B. ZhouH.P. LiuX.H. New arylpyrazoline-coumarins: Synthesis and anti-inflammatory activity.Eur. J. Med. Chem.201713817018110.1016/j.ejmech.2017.06.044 28667873
    [Google Scholar]
82. CaiX. ZhaoS. CaiD. ZhengJ. ZhuZ. WeiD. ZhengZ. ZhuH. ChenY. Synthesis and evaluation of novel D-ring substituted steroidal pyrazolines as potential anti-inflammatory agents.Steroids2019146707810.1016/j.steroids.2019.03.012 30951758
    [Google Scholar]
83. VivekaS. DineshaP. ShamaP. NagarajaG.K. BallavS. KerkarS. Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.Eur. J. Med. Chem.201510144245110.1016/j.ejmech.2015.07.002 26186150
    [Google Scholar]
84. RaniP. SrivastavaV.K. KumarA. Synthesis and antiinflammatory activity of heterocyclic indole derivatives.Eur. J. Med. Chem.200439544945210.1016/j.ejmech.2003.11.002 15110970
    [Google Scholar]
85. BarsoumF.F. GirgisA.S. Facile synthesis of bis(4,5-dihydro-1H-pyrazole-1-carboxamides) and their thio-analogues of potential PGE2 inhibitory properties.Eur. J. Med. Chem.20094452172217710.1016/j.ejmech.2008.10.020 19056146
    [Google Scholar]
86. GirishaK.S. KallurayaB. NarayanaV. PadmashreeP. Synthesis and pharmacological study of 1-acetyl/propyl-3-aryl-5-(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-pyrazoline.Eur. J. Med. Chem.201045104640464410.1016/j.ejmech.2010.07.032 20702008
    [Google Scholar]
87. KhodeS. MaddiV. AragadeP. PalkarM. RonadP.K. MamledesaiS. ThippeswamyA.H.M. SatyanarayanaD. Synthesis and pharmacological evaluation of a novel series of 5-(substituted)aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines as novel anti-inflammatory and analgesic agents.Eur. J. Med. Chem.20094441682168810.1016/j.ejmech.2008.09.020 18986738
    [Google Scholar]
88. GodoyM.C.M. FigheraM.R. SouzaF.R. FloresA.E. RubinM.A. OliveiraM.R. ZanattaN. MartinsM.A.P. BonacorsoH.G. MelloC.F. α2-Adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazolines, but not of dipyrone.Eur. J. Pharmacol.20044961-3939710.1016/j.ejphar.2004.05.045 15288580
    [Google Scholar]
89. ShenoyG.G. BhatA.R. BhatG.V. KotianM. Synthesis and antimicrobial activities of 1,3,5 trisubstituted 2-pyrazolines.Indian J. Heterocycl. Chem.200110197200
    [Google Scholar]
90. ShaharyarM. SiddiquiA.A. AliM.A. SriramD. YogeeswariP. Synthesis and in vitro antimycobacterial activity of] N1-nicotinoyl-3-(4′-hydroxy-3′-methylphenyl)-5-[(sub)phenyl]-2-pyrazolines.Bioorg. Med. Chem. Lett.200616153947394910.1016/j.bmcl.2006.05.024 16725324
    [Google Scholar]
91. HayatF. SalahuddinA. UmarS. AzamA. Synthesis, characterization, antiamoebic activity and cytotoxicity of novel series of pyrazoline derivatives bearing quinoline tail.Eur. J. Med. Chem.201045104669467510.1016/j.ejmech.2010.07.028 20696501
    [Google Scholar]
92. BudakotiA. AbidM. AzamA. Syntheses, characterization and in vitro antiamoebic activity of new Pd(II) complexes with 1-N-substituted thiocarbamoyl-3,5-diphenyl-2-pyrazoline derivatives.Eur. J. Med. Chem.200742454455110.1016/j.ejmech.2006.10.011 17156895
    [Google Scholar]
93. AbidM. AzamA. Synthesis and antiamoebic activities of 1-N-substituted cyclised pyrazoline analogues of thiosemicarbazones.Bioorg. Med. Chem.20051362213222010.1016/j.bmc.2004.12.050 15727873
    [Google Scholar]
94. AbidM. BhatA.R. AtharF. AzamA. Synthesis, spectral studies and antiamoebic activity of new 1-N-substituted thiocarbamoyl-3-phenyl-2-pyrazolines.Eur. J. Med. Chem.200944141742510.1016/j.ejmech.2007.10.032 18068873
    [Google Scholar]
95. DuX. GuoC. HansellE. DoyleP.S. CaffreyC.R. HollerT.P. McKerrowJ.H. CohenF.E. Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain.J. Med. Chem.200245132695270710.1021/jm010459j 12061873
    [Google Scholar]
96. MatiadisD. SaporitiT. AguileraE. RobertX. GuillonC. CabreraN. Pérez-MontfortR. SagnouM. AlvarezG. Pyrazol(in)e derivatives of curcumin analogs as a new class of anti- Trypanosoma cruzi agents.Future Med. Chem.202113870171410.4155/fmc‑2020‑0349 33648346
    [Google Scholar]
97. SaeedM.E.M. KrishnaS. GretenH.J. KremsnerP.G. EfferthT. Antischistosomal activity of artemisinin derivatives in vivo and in patients.Pharmacol. Res.201611021622610.1016/j.phrs.2016.02.017 26902577
    [Google Scholar]
98. MoraisC.S. MengardaA.C. MiguelF.B. EnesK.B. RodriguesV.C. Espírito-SantoM.C.C. SiyadatpanahA. WilairatanaP. CouriM.R.C. de MoraesJ. de MoraesJ. Pyrazoline derivatives as promising novel antischistosomal agents.Sci. Rep.20211112343710.1038/s41598‑021‑02792‑0 34873205
    [Google Scholar]
99. SilverK.S. SoderlundD.M. Action of pyrazoline-type insecticides at neuronal target sites.Pestic. Biochem. Physiol.200581213614310.1016/j.pestbp.2004.09.003
    [Google Scholar]
100. PéterfiO. BodaF. SzabóZ. FerenczE. BábaL. Hypotensive snake venom components-A mini-review.Molecules20192415277810.3390/molecules24152778 31370142
     [Google Scholar]
101. Turan-ZitouniG. ChevalletP. KiliçF.S. ErolK. Synthesis of some thiazolyl-pyrazoline derivatives and preliminary investigation of their hypotensive activity.Eur. J. Med. Chem.200035663564110.1016/S0223‑5234(00)00152‑5 10906414
     [Google Scholar]
102. Puig-BasagoitiF. TilgnerM. ForsheyB.M. PhilpottS.M. EspinaN.G. WentworthD.E. GoebelS.J. MastersP.S. FalgoutB. RenP. FergusonD.M. ShiP.Y. Triaryl pyrazoline compound inhibits flavivirus RNA replication.Antimicrob. Agents Chemother.20065041320132910.1128/AAC.50.4.1320‑1329.2006 16569847
     [Google Scholar]
103. Pachuta-StecA. Antioxidant activity of 1,2,4-triazole and its derivatives: A mini-review.Mini Rev. Med. Chem.20222271081109410.2174/1389557521666210401091802 33797373
     [Google Scholar]
104. HavrylyukD. ZimenkovskyB. VasylenkoO. DayC.W. SmeeD.F. GrellierP. LesykR. Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones.Eur. J. Med. Chem.20136622823710.1016/j.ejmech.2013.05.044 23811085
     [Google Scholar]
105. SrinivasanK.K. BabuV.H. SrideviC.H. JosephA. Synthesis and biological evaluation of some novel pyrazolines.Indian J. Pharm. Sci.200769347047310.4103/0250‑474X.34569
     [Google Scholar]